Cara Therapeutics Cash from Investing (TTM) Insights

Cara Therapeutics Inc (CARA)

0.7122 -0.05 (-6.30%) USD | NASDAQ | May 10, 16:00

0.7122 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	43.46M
September 30, 2023	118.09M
June 30, 2023	116.11M
March 31, 2023	112.98M
December 31, 2022	128.71M
September 30, 2022	30.70M
June 30, 2022	23.96M
March 31, 2022	14.81M
December 31, 2021	-4.751M
September 30, 2021	-115.32M
June 30, 2021	-90.22M
March 31, 2021	-43.36M
December 31, 2020	-20.28M
September 30, 2020	158.62M
June 30, 2020	22.20M
March 31, 2020	-19.96M
December 31, 2019	-30.52M
September 30, 2019	-103.08M
June 30, 2019	-0.75M
March 31, 2019	-77.11M

Date	Value
December 31, 2018	-82.82M
September 30, 2018	-16.86M
June 30, 2018	-10.24M
March 31, 2018	-30.51M
December 31, 2017	-36.50M
September 30, 2017	-24.09M
June 30, 2017	-21.38M
March 31, 2017	57.10M
December 31, 2016	45.02M
September 30, 2016	-67.19M
June 30, 2016	-81.97M
March 31, 2016	-89.06M
December 31, 2015	-91.68M
September 30, 2015	-0.028M
June 30, 2015	-0.048M
March 31, 2015	-0.048M
December 31, 2014	-0.042M
September 30, 2014	-0.028M
June 30, 2014	-0.011M
March 31, 2014	-0.005M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-115.32M

Minimum

Sep 2021

158.62M

Maximum

Sep 2020

17.97M

Average

14.81M

Median

Mar 2022

Cash from Investing (TTM) Benchmarks